BD FACSLyric
BD FACSLyric
Massive $175B Merger Set to Transform Waters!
BIOT
💰 Waters merges with BD's Biosciences for $17.5B! 📈 Expect a $40B market size and $200M savings by 2026! 🔍🗓️
Genezen Revolutionizes Vector Production with CSL Licensing
BIOT
📢 Genezen becomes first CDMO to license CSL's Cytegrity system, helping to alleviate viral vector shortage and improve quality. 🚀👩🔬💊
Unlocking Flow Cytometry’s Secrets: Consistent Results Made Simple!
BIOT
🔬⚖️ Consistent quality control & standardization are crucial in flow cytometry for accurate & reliable results. Discover BD FACSLyric™ Flow Cytometer! 👩🔬🔬📊 Note: BD is the sponsor of this article. Register on the website to learn more and download the application note.
